Patients were randomly assigned to receive either Protonix 40 mg IV, Protonix Delayed-Release Tablets 40 mg, or placebo once daily for 7 days. MAO and BAO were evaluated 24 hours after the last ...
Patients received either Protonix 10 mg, 20 mg, or 40 mg delayed-release tablets once daily or ranitidine 150 mg twice daily. Protonix 20 mg and 40 mg was significantly superior to ranitidine at ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback